Skip to main content

Levetiracetam

NDC 60429-350 · Golden State Medical Supply, Inc.

Generic nameLevetiracetam
Dosage formTABLET, FILM COATED, EXTENDED RELEASE
RouteORAL
Active ingredient(s)LEVETIRACETAM
Strength750 mg/1
Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

60429-350-60 — 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (60429-350-60)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55150-246 — Levetiracetam in sodium chloride, 55150-247 — Levetiracetam in sodium chloride, 55150-248 — Levetiracetam in sodium chloride, 55154-3367 — Levetiracetam, 55154-4171 — Levetiracetam, 55154-4316 — LEVETIRACETAM, 55154-5699 — levetiracetam, 55154-5782 — LEVETIRACETAM, 58657-860 — levetiracetam, 60429-349 — Levetiracetam, 60505-3280 — Levetiracetam, 60505-3517 — Levetiracetam, 60505-3518 — Levetiracetam, 60687-249 — Levetiracetam, 60687-657 — Levetiracetam, 60687-668 — Levetiracetam, 62135-548 — LEVETIRACETAM, 63187-360 — Levetiracetam, 63323-400 — LEVETIRACETAM, 63629-4137 — Levetiracetam, +277 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels